Search - tctmd.com

Displaying 841 - 860 of 984

Sort: Relevancy | Date

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

Presentation TCT 2013

TCT-8. 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent:...

Presenter: Byoung Kwon Lee

October 29, 2013

Presentation TCT 2013

TCT-7. Impact Of Early Versus Late Clopidogrel Discontinuation On Stent Thrombosis Following Percutaneous Coronary Intervention With First- And Second-Generation Drug-Eluting...

Presenter: Joshua Loh

October 29, 2013

Presentation TCT 2013

TCT-6. Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results from the ADAPT-DES Registry

Presenter: Usman Baber

October 29, 2013

Presentation TCT 2013

TCT-3. Outcomes in STEMI patients treated with clopidogrel or prasugrel: A propensity adjusted analysis from the INFUSE-AMI Trial

Presenter: Keith Oldroyd

October 29, 2013

Presentation TCT 2013

TCT-10. Differences Between US and non-US Cohorts after PCI and Dual Antiplatelet Therapy: Patient Characteristics, Randomization

Presenter: Laura Mauri

October 29, 2013

Presentation TCT 2013

TCT-9. Racial Disparity With On-Treatment Platelet Reactivity In Patients Undergoing Percutaneous Coronary Intervention

Presenter: Iakshmana Pendyala

October 29, 2013

Presentation TCT 2013

TCT-5. Relationship Between High Platelet Reactivity on Clopidogrel and Outcomes After DES Implantation: Two-Year Results From the ADAPT-DES Study

Presenter: Thomas Stuckey

October 29, 2013

Presentation TCT 2013

TCT-4. Efficacy and Safety of Concurrent Administration of Clopidogrel-loading (600mg) and Prasugrel-loading (60mg) in Patients with Acute ST-Segment Elevation Myocardial...

Presenter: Lorenz Raber

October 29, 2013

Presentation TCT 2013

TCT-2. Comparative Effectiveness of Prasugrel vs. Clopidogrel Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: 30-Day Outcomes from th...

Presenter: Tracy Wang

October 29, 2013

Presentation TCT 2013

TCT-1. Do Proton Pump Inhibitors Interact With Clopidogrel? Insights From ADAPT-DES

Presenter: Michael Rinaldi

October 29, 2013

News Conference News TCT 2013

SYNTAX Cost-effectiveness Analysis Supports Existing Guidelines

October 29, 2013

News Conference News TCT 2013

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

October 29, 2013

News Conference News TCT 2013

Paclitaxel-Coated Balloons Show Promise in Two Studies

October 29, 2013

News Conference News TCT 2013

Intraprocedural ST Predicts Adverse Short-Term Events

October 29, 2013

Presentation TCT 2013

Selecting the Best Antiplatelet Strategy for ACS and Stable CAD

Presenter: Oscar Mendiz

October 28, 2013

Presentation TCT 2013

Making Treatment Decisions for Complex CAD: PCI vs. CABG

Presenter: Isaac George

October 28, 2013

Presentation TCT 2013

FFR-Guided PCI vs. Bypass Graft Surgery for Triple Vessel and Left Main CAD: Does Physiologic Guidance Change the Equation

Presenter: Seung-Jung Park

October 28, 2013

Presentation TCT 2013

Evolution of the AUC Terminology, and Current Recommendations in Stable CAD

Presenter: Manesh Patel

October 28, 2013

Presentation TCT 2013

Case #1: Complex CAD: PCI or CABG?

Presenter: Miodrag Ostojic

October 28, 2013

Advertisement

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

TCT-8. 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent:...

TCT-7. Impact Of Early Versus Late Clopidogrel Discontinuation On Stent Thrombosis Following Percutaneous Coronary Intervention With First- And Second-Generation Drug-Eluting...

TCT-6. Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results from the ADAPT-DES Registry

TCT-3. Outcomes in STEMI patients treated with clopidogrel or prasugrel: A propensity adjusted analysis from the INFUSE-AMI Trial

TCT-10. Differences Between US and non-US Cohorts after PCI and Dual Antiplatelet Therapy: Patient Characteristics, Randomization

TCT-9. Racial Disparity With On-Treatment Platelet Reactivity In Patients Undergoing Percutaneous Coronary Intervention

TCT-5. Relationship Between High Platelet Reactivity on Clopidogrel and Outcomes After DES Implantation: Two-Year Results From the ADAPT-DES Study

TCT-4. Efficacy and Safety of Concurrent Administration of Clopidogrel-loading (600mg) and Prasugrel-loading (60mg) in Patients with Acute ST-Segment Elevation Myocardial...

TCT-2. Comparative Effectiveness of Prasugrel vs. Clopidogrel Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: 30-Day Outcomes from th...

TCT-1. Do Proton Pump Inhibitors Interact With Clopidogrel? Insights From ADAPT-DES

SYNTAX Cost-effectiveness Analysis Supports Existing Guidelines

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

Paclitaxel-Coated Balloons Show Promise in Two Studies

Intraprocedural ST Predicts Adverse Short-Term Events

Selecting the Best Antiplatelet Strategy for ACS and Stable CAD

Making Treatment Decisions for Complex CAD: PCI vs. CABG

FFR-Guided PCI vs. Bypass Graft Surgery for Triple Vessel and Left Main CAD: Does Physiologic Guidance Change the Equation

Evolution of the AUC Terminology, and Current Recommendations in Stable CAD

Case #1: Complex CAD: PCI or CABG?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content